Category: News
-

I’m surprised Zillow just hid climate risk scores — and here’s why that matters for buyers
Zillow removed First Street climate-risk scores from 1M+ listings after agent pressure. That reduces upfront transparency and raises liability,…
-

I’m surprised OpenAI bought into a roll‑up — and honestly, I’m worried
OpenAI’s stake in Thrive Holdings and embedded teams creates preferential data and product loops. It will accelerate startups, raise valuations, and…
-

I just read about Europol shutting a crypto mixer that allegedly laundered €1.3B
Europol-led takedown of Cryptomixer seized €25M, servers and 12TB of data, disrupting an estimated €1.3B laundering channel and raising tracing and…
-

I’m seeing construction workers cash in on the AI data‑center boom — here’s why
Data‑center demand and AI tools are driving 25–30% wage gains and new perks. What CFOs and product leaders must know about costs, risks, and deployment…
-

Amazon’s Rufus drove Black Friday conversions — I’m impressed, but here’s the catch
Rufus-driven sessions doubled purchase rates on Black Friday; AI referral traffic surged 805% YoY. Executives should track attribution, margins, privacy…
-

I just read BloombergNEF’s data-center shocker — and it should worry every grid operator I know
BloombergNEF forecasts U.S. data-center load rising from 40 GW to 106 GW by 2035. Here’s what that means for grids, costs, and operator actions.
-

I read Coupang’s breach report — 33.7M records exposed and I’m worried about what they didn’t say
Coupang confirmed a 33.7M-customer data breach. This briefing explains the immediate business impact, regulatory risks, likely attack vectors, and four…
-

I just counted 80+ new tech unicorns this year — AI dominates, but there’s a catch
TechCrunch tracked 80+ VC-backed unicorns this year. AI leads the surge, but hiring, valuations, and regulatory risk are the real business decisions.
-

I just saw Black Forest Labs raise $300M — this changes image AI, but here’s the catch
Black Forest Labs raised $300M at a $3.25B valuation to scale FLUX.2 (up to 4K, multi-image conditioning). What operators must budget, audit, and test…
-

I just heard Varda proved “space-made” drugs work — but there’s a big catch
Varda returned ritonavir crystals from orbit and sells a launch-driven pharma model. Here’s what changes for launch economics, pharma R&D, and regulatory…